Ondrey Aaron 4
4 · Mirati Therapeutics, Inc. · Filed Sep 12, 2023
Insider Transaction Report
Form 4
Ondrey Aaron
Interim CFO
Transactions
- Award
Common Stock
2023-09-08$35.66/sh+8,412$299,972→ 22,440 total
Footnotes (1)
- [F1]This represents a Performance Share Unit Award and shares shall vest in full on the earlier of (i) 90 days following commencement of employment of a permanent CFO, (ii) involuntary termination of employment (not for Cause).